Celegene getting hammered
The major US stock indices are opening up. Nasdaq lags
Celegene is getting hammered down -$23 or nearly 20% to $96. The drug company reported lower than expected revenues. Last Friday they said they were abandoning two drugs to combat Crohns disease. The stock traded as high at $147 on October 2nd.
Copyright 2015 Forexlive.com